Literature DB >> 34895945

Network pharmacology: curing causal mechanisms instead of treating symptoms.

Cristian Nogales1, Zeinab M Mamdouh2, Markus List3, Christina Kiel4, Ana I Casas5, Harald H H W Schmidt6.   

Abstract

For complex diseases, most drugs are highly ineffective, and the success rate of drug discovery is in constant decline. While low quality, reproducibility issues, and translational irrelevance of most basic and preclinical research have contributed to this, the current organ-centricity of medicine and the 'one disease-one target-one drug' dogma obstruct innovation in the most profound manner. Systems and network medicine and their therapeutic arm, network pharmacology, revolutionize how we define, diagnose, treat, and, ideally, cure diseases. Descriptive disease phenotypes are replaced by endotypes defined by causal, multitarget signaling modules that also explain respective comorbidities. Precise and effective therapeutic intervention is achieved by synergistic multicompound network pharmacology and drug repurposing, obviating the need for drug discovery and speeding up clinical translation.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  biomarkers; cancer; cardiovascular; disease modules; network pharmacology

Mesh:

Year:  2021        PMID: 34895945     DOI: 10.1016/j.tips.2021.11.004

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  27 in total

1.  Based on network pharmacology and in vitro experiments to prove the effective inhibition of myocardial fibrosis by Buyang Huanwu decoction.

Authors:  Tianyue Wang; Xinyu Jiang; Yanmin Ruan; Jun Zhuang; Yuanjun Yin
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 2.  Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process.

Authors:  Md Rifat Hasan; Ahad Amer Alsaiari; Burhan Zain Fakhurji; Mohammad Habibur Rahman Molla; Amer H Asseri; Md Afsar Ahmed Sumon; Moon Nyeo Park; Foysal Ahammad; Bonglee Kim
Journal:  Molecules       Date:  2022-06-29       Impact factor: 4.927

Review 3.  NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook.

Authors:  Alberto Nascè; Karim Gariani; François R Jornayvaz; Ildiko Szanto
Journal:  Antioxidants (Basel)       Date:  2022-06-09

4.  MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen.

Authors:  Richard E Kast; Alex Alfieri; Hazem I Assi; Terry C Burns; Ashraf M Elyamany; Maria Gonzalez-Cao; Georg Karpel-Massler; Christine Marosi; Michael E Salacz; Iacopo Sardi; Pieter Van Vlierberghe; Mohamed S Zaghloul; Marc-Eric Halatsch
Journal:  Cancers (Basel)       Date:  2022-05-23       Impact factor: 6.575

5.  Deciphering Risperidone-Induced Lipogenesis by Network Pharmacology and Molecular Validation.

Authors:  Yun Fu; Ke Yang; Yepei Huang; Yuan Zhang; Shen Li; Wei-Dong Li
Journal:  Front Psychiatry       Date:  2022-04-18       Impact factor: 5.435

6.  Study on Mechanism of Yiqi Yangyin Jiedu Recipe Inhibiting Triple Negative Breast Cancer Growth: A Network Pharmacology and In Vitro Verification.

Authors:  Xin Sun; Panling Xu; Fengli Zhang; Ting Sun; Haili Jiang; Mei Zhang; Ping Li
Journal:  J Oncol       Date:  2022-03-27       Impact factor: 4.375

7.  Mechanistic Investigation of Curcuma Protection against Oral Submucous Fibrosis.

Authors:  Haiyan Peng; Xiaowen Jiang; Linna Cui; Yali Zhu; Zhikui Ye; Zhiming Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-09       Impact factor: 2.650

8.  Galangin Exhibits Neuroprotective Effects in 6-OHDA-Induced Models of Parkinson's Disease via the Nrf2/Keap1 Pathway.

Authors:  Qiu-Xu Chen; Ling Zhou; Tao Long; Da-Lian Qin; Yi-Ling Wang; Yun Ye; Xiao-Gang Zhou; Jian-Ming Wu; An-Guo Wu
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-17

9.  Whole Transcriptome Analysis Identifies Platycodin D-Mediated RNA Regulatory Network in Non-Small-Cell Lung Cancer.

Authors:  Shuyu Zheng; Zejuan Xie; Yanlin Xin; Wenli Lu; Hao Yang; Tianming Lu; Jun Li; Shanshan Wang; Keyu Cheng; Xi Yang; Ruogu Qi; Yongming Qiu; Yuanyuan Guo
Journal:  Cells       Date:  2022-08-01       Impact factor: 7.666

10.  Evaluating the therapeutic role of selected active compounds in Plumula Nelumbinis on pulmonary hypertension via network pharmacology and experimental analysis.

Authors:  Xinghua Xiao; Fangmei Luo; Minyi Fu; Yueping Jiang; Shao Liu; Bin Liu
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.